INNOVHEM is part of the 4th promotion of SISTA Entrepreneures with AXA FRANCE. This program aims to support the financing of companies run by women.
Measure HbF at the single-cell level is no longer optional—it is essential for advancing sickle cell disease care. First, at #ASH2025, Prof. Martin...
Paris, France – October 14, 2025 – Innovhem announces its co-founder and CEO Marie Cambot has been awarded Chevalier de l’Ordre National du Mérite....
Innovhem proudly shares its latest scientific publication in Haematologica Journal, highlighting our commitment to advancing hematology research. In...
Aventure France 2030 ! 🏆 Hier, à Paris, se tenait le Comité interministériel de l'innovation C2i. Nous sommes fiers de faire partie de...
Another step forward in the fight against sickle cell disease ! On the occasion of the state visit to France by Their Majesties King Frederik X and...
Innovhem to present New data on single-cell quantification of HbF and HbS at the 2024 ASH Annual Meeting. One poster presentation to feature new...